The federal government’s 340B Drug Pricing Program is designed to deliver significant drug price savings to eligible health care organizations and their patients. Special guest speaker Jeff Davis, of Baker Donelson, will present regulatory and compliance insights for safety net hospitals to consider when managing their 340B programs. Information presented will empower hospitals and FQHC’s to position their entity for the changes currently being explored in the 340B marketplace.
DATE: Tuesday, March 10th 2020
TIME: 2:00 pm – 3:00 pm EST (1:00 pm – 2:00 pm CST)
SPONSOR: SUNRx
Presenter: Jeff Davis is Counsel in Baker Donelson’s Washington, DC office. He is a Senior Advisor in the firm’s Government Relations and Public Policy Group. Jeff provides clients with health care regulatory counsel on issues affecting health care providers, including Medicare and Medicaid billing and reimbursement. He assists hospitals, pharmacies, other health care providers, and vendors on issues related to the federal 340B drug pricing program, including enrollment; contracting; audits; compliance with 340B, Medicare, and Medicaid requirements; and self-disclosures. Prior to joining the Firm, Jeff served as vice president and legislative and policy counsel for 340B Health, a nonprofit organization of more than 1,300 hospitals and health systems participating in the 340B drug pricing program. During his more than seven years with 340B Health, he provided hospitals with technical assistance on 340B, Medicare, and Medicaid program compliance issues, oversaw research and policy efforts, and helped lead the government relations team in their work to educate members of Congress and their staff on the importance of the 340B program to hospitals and their patients.
SDAHO Enterprise was developed to pursue valued services and increase non-dues revenue. Overall goals and objectives of providing revenue to supplement SDAHO strategies and providing support and benefit to members.​​​​
